Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Stimulant Involvement in Opioid OD Death Higher for Those in Physically Demanding Jobs

A higher percentage of individuals who have psychostimulant involvement in synthetic opioid overdose deaths tend to work in physically demanding occupations and

Subclinical Cardiac Dysfunction Linked to Markers of Neurodegeneration

Subclinical cardiac dysfunction is associated with brain imaging markers of neurodegeneration, according to a study published online March 26 in Neurology. Ambe

AI Model Can Optimize, Standardize Total Parenteral Nutrition Formulas

An artificial intelligence (AI) approach identified total parenteral nutrition (TPN) formulas that increase safety and potentially reduce costs for neonates adm

Similar Efficacy Seen for Isodose, Dose-Escalated MHFRT, CFRT in Prostate Cancer

For patients with prostate cancer, isodose and dose-escalated moderately hypofractionated radiotherapy (MHFRT) have similar efficacy as conventionally fractiona

Fasting Outperforms Calorie Cutting, Clinical Trial Says

Fasting every other day can prompt more weight loss than simply cutting calories, a new clinical trial shows. People who undertook 4 3 intermittent fasting lost

GLP-1 Drug Use For Weight Loss Has Soared, Costing Billions

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent years, a new study says. The number of

Navigators Help Patients Get Colonoscopy For Suspected Cancer

Personalized support can help more people at risk of colon cancer attend a potentially life-saving colonoscopy appointment, a new study says. About 55 of people

Pregnant Women, New Moms Dying More Often From Heart Conditions

The heart-related death rate among pregnant women and new mothers more than doubled between 1999 and 2022, researchers have found. Just under 9.1 mothers for ev

Lilly's Lepodisiran Reduced Levels of Genetically Inherited Heart Disease Risk Factor, Lipoprotein(a), by Nearly 94% from Baseline at the Highest Tested Dose in Adults with Elevated Levels

Eli Lilly and Company (NYSE LLY) today announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA (siRNA) therapy designed to

AZD0780, a Novel Oral PCSK9 Inhibitor, Demonstrated Significant LDL Cholesterol (LDL-C) Reduction in PURSUIT Phase IIb Trial

Positive results from the PURSUIT Phase IIb trial for AstraZeneca s AZD0780 demonstrated a statistically significant low-density lipoprotein cholesterol (LDL-C)

Popular Keywords